{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:16:25Z","timestamp":1787962585248,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Genetics and Genomics Advances"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xhgg.2026.100617","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:12:11Z","timestamp":1776899531000},"page":"100617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of von Hippel Lindau gene variants in an African American cohort"],"prefix":"10.1016","volume":"7","author":[{"given":"Yusra F.","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4159-7255","authenticated-orcid":false,"given":"Diana","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Rahman","family":"Alloghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Al Share","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Kokenakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1381-2713","authenticated-orcid":false,"given":"Elisabeth","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xhgg.2026.100617_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease : A genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.xhgg.2026.100617_bib2","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.2147\/OTT.S190753","article-title":"Von Hippel-Lindau Disease\u202f: Current Challenges and Future Prospects","volume":"13","author":"Gl\u00e4sker","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.xhgg.2026.100617_bib3","series-title":"WHO Classification of Tumours of Endocrine Organs","first-page":"257","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.xhgg.2026.100617_bib4","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O\u2019Brien","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2026.100617_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease correlations with germline VHL gene mutations","volume":"33","author":"Maher","year":"1996","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.xhgg.2026.100617_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.xhgg.2026.100617_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1349-7006.2000.tb00933.x","article-title":"Germ-line mutation analysis in participants with von Hippel-Lindau disease in Japan: An extended study of 77 families","volume":"91","author":"Yoshida","year":"2000","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.xhgg.2026.100617_bib8","first-page":"703","article-title":"MH: Results of mutation analyses of Von-Hippel-Lindau Disease gene in Japanese participants: Comparison with results in United States and United Kingdom","volume":"41","author":"Shuin","year":"1995","journal-title":"Hinyokika Kiyo"},{"key":"10.1016\/j.xhgg.2026.100617_bib9","first-page":"47","article-title":"Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease","volume":"29","author":"Huang","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.xhgg.2026.100617_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3346\/jkms.2009.24.1.77","article-title":"Improved detection of germline mutations in Korean VHL participants by multiple ligation-dependent probe amplification analysis","volume":"24","author":"Cho","year":"2009","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.xhgg.2026.100617_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41436-019-0502-5","article-title":"The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2026.100617_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1470-2045(25)00099-3","article-title":"Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up for single-arm, phase 2 study","volume":"26","author":"Srinivasan","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xhgg.2026.100617_bib13","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0260","article-title":"Genotype-specific neoplastic risk profiles in patients with VHL disease","volume":"32","author":"Ganner","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.xhgg.2026.100617_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: A comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2026.100617_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162480","article-title":"Von Hippel\u2013Lindau disease: insights into oxygen sensing, protein degradation, and cancer","volume":"132","author":"Kaelin","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xhgg.2026.100617_bib16","series-title":"Donna Vickery SST: Phase 2 study of the oral hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) inhibitor MK-6482 in combination with cabozantinib in participants with advanced clear cell renal cell carcinoma (ccRCC)","author":"Choueiri","year":"2022"},{"key":"10.1016\/j.xhgg.2026.100617_bib17","doi-asserted-by":"crossref","first-page":"LBA417","DOI":"10.1200\/JCO.2026.44.7_suppl.LBA417","article-title":"Abstract 417: Belzutifan (bel) plus Lenvatinib (lenva) versus cabozantinib (cabo) for advanced renal cell carcinoma (RCC) after anti\u2013PD-(L)1 therapy: Open-label phase 3 LITESPARK-011 study","volume":"44","author":"Motzer","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xhgg.2026.100617_bib18","doi-asserted-by":"crossref","first-page":"LBA418","DOI":"10.1200\/JCO.2026.44.7_suppl.LBA418","article-title":"Abstract LBA418: Adjuvant pembrolizumab plus Belzutifan versus pembrolizumab for clear cell renal cell carcinoma (ccRCC): The randomized phase 3 LITESPARK-022 study","volume":"44","author":"Choueiri","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xhgg.2026.100617_bib19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1538-7445.AM2021-1206","article-title":"Abstract 1206: Discovery and characterization of AB521, a novel, potent, and selective hypoxia-inducible factor (HIF)-2\u03b1 inhibitor","volume":"81","author":"Lawson","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xhgg.2026.100617_bib21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/oncolo\/oyac132","article-title":"The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Participants","volume":"27","author":"Choi","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.xhgg.2026.100617_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cge.14006","article-title":"Out-of-pocket and private pay in clinical genetic testing: A scoping review","volume":"100","author":"Grant","year":"2021","journal-title":"Clin. Genet."},{"key":"10.1016\/j.xhgg.2026.100617_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000540341","article-title":"Sociodemographic and Clinical Characteristics Associated with Genetic Testing among Cancer Survivors: Evidence from Three Cancer Registries","volume":"27","author":"Hong","year":"2024","journal-title":"Public Health Genom."}],"container-title":["Human Genetics and Genomics Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247726000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247726000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:18:57Z","timestamp":1787959137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666247726000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666247726000576"],"URL":"https:\/\/doi.org\/10.1016\/j.xhgg.2026.100617","relation":{},"ISSN":["2666-2477"],"issn-type":[{"value":"2666-2477","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of von Hippel Lindau gene variants in an African American cohort","name":"articletitle","label":"Article Title"},{"value":"Human Genetics and Genomics Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xhgg.2026.100617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society of Human Genetics.","name":"copyright","label":"Copyright"}],"article-number":"100617"}}